Purple Biotech Ltd.PPBTNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank90
3Y CAGR+153.2%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+153.2%/yr
Quarterly compound
Percentile
P90
Near historical high
vs 3Y Ago
16.2x
Strong expansion
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 34.66% |
| Q2 2025 | 21.94% |
| Q1 2025 | 1.79% |
| Q4 2024 | 38.88% |
| Q3 2024 | 17.13% |
| Q2 2024 | 21.76% |
| Q1 2024 | -2.01% |
| Q4 2023 | -36.27% |
| Q3 2023 | 30.00% |
| Q2 2023 | 13.87% |
| Q1 2023 | -43.90% |
| Q4 2022 | -16.38% |
| Q3 2022 | 2.14% |
| Q2 2022 | 28.85% |
| Q1 2022 | -38.56% |
| Q4 2021 | -27.65% |
| Q3 2021 | 42.13% |
| Q2 2021 | -46.06% |
| Q1 2021 | -93256.60% |
| Q4 2020 | 0.00% |
| Q3 2020 | -60.55% |
| Q2 2020 | 0.00% |
| Q1 2020 | -40.17% |
| Q4 2019 | 0.00% |
| Q3 2019 | -45.86% |
| Q2 2019 | 0.00% |
| Q1 2019 | 54.58% |
| Q4 2018 | 0.00% |
| Q3 2018 | -43.54% |
| Q2 2018 | 0.00% |
| Q1 2018 | 11.53% |
| Q4 2017 | 0.00% |
| Q3 2017 | 16.09% |
| Q2 2017 | 0.00% |
| Q1 2017 | -22.32% |
| Q4 2016 | 0.00% |
| Q3 2016 | -58.01% |
| Q2 2016 | 0.00% |
| Q1 2016 | 99.87% |
| Q4 2015 | 13.62% |